China’s drug regulator seeks comments on updated drug recalls regulation

Published date15 October 2020
Subject MatterLife Sciences,China,Product Recalls,Prescription Drugs,Regulatory Standards,Regulatory Agenda,Product Defects,Pharmaceutical Industry
AuthorJames Johnson,Xin Tao
Law FirmHogan Lovells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT